Nancy Stuart's Net Worth
$2.38 Million
Who is Nancy Stuart?
Nancy Stuart has an estimated net worth of $2.38 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., and CONCERT PHARMACEUTICALS, INC..
SEC CIK
Nancy Stuart's CIK is 0001594774
Past Insider Trading and Trends
2015 was Nancy Stuart's most active year for acquiring shares with 4 total transactions. Nancy Stuart's most active month to acquire stocks was the month of December. 2023 was Nancy Stuart's most active year for disposing of shares, totalling 13 transactions. Nancy Stuart's most active month to dispose stocks was the month of February. 2018 saw Nancy Stuart paying a total of $223,879.56 for 118,882 shares, this is the most they've acquired in one year. In 2015 Nancy Stuart cashed out on 166,944 shares for a total of $1,290,049.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $12.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CONCERT PHARMACEUTICALS, INC. No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -241.20K |
—
|
—
|
0
|
Mar 6
| |||
Form 4
| -2.25% | -6.05K |
$8.33 | -$50,379.84 | 262.6K |
Scheduled
|
Feb 15
| ||
Form 4
| -4.68% | -13.20K |
$8.35 | -$110,220.00 | 268.64K |
Scheduled
|
Jan 30
| ||
Form 4
| -1.02% | -2.89K |
$7.25 | -$20,974.25 | 281.84K |
Scheduled
|
Jan 6
| ||
Form 4
| -2.08% | -6.05K |
$3.08 | -$18,630.92 | 284.74K |
Scheduled
|
Feb 14
| ||
Form 4
| +70.66% | 120.4K |
—
|
—
| 290.79K |
Jan 28
| |||
Form 4
| -1.67% | -2.89K |
$3.19 | -$9,231.86 | 170.39K |
Scheduled
|
Jan 5
| ||
Form 4
| -3.37% | -6.05K |
$7.32 | -$44,278.68 | 173.28K |
Scheduled
|
Feb 16
| ||
Form 4
| +13.77% | 21.7K |
—
|
—
| 179.33K |
Jan 5
| |||
Form 4
| +7.46% | 10.94K |
$7.57 | -$36,201.81 | 157.63K |
Jun 22
| |||
Form 4
| +44.77% | 45.36K |
—
|
—
| 146.69K |
Feb 14
| |||
Form 4
| +2.51% | 2.48K |
$6.01 | $5.60 | 101.32K |
Dec 4
| |||
Form 4
| -8.21% | -8.84K |
$12.07 | -$106,638.45 | 98.84K |
Mar 31
| |||
Form 4
| +22.21% | 19.57K |
$9.18 | $4.86 | 107.68K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -2.06% | -1.85K |
—
|
—
| 88.11K |
Nov 29
| |||
Form 4
| -25.88% | -31.42K |
$17.87 | -$561,587.33 | 89.96K |
Scheduled
|
Jul 9 - Jul 10
| ||
Form 4/A
| -3.51% | -4.42K |
$22.90 | -$101,172.20 | 121.38K |
Mar 31
| |||
Form 4
| -3.14% | -4.42K |
$22.90 | -$101,172.20 | 136.38K |
Mar 31
| |||
Form 4
| +36.72% | 37.82K |
$12.41 | $14.38 | 140.79K |
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +2.06% | 2.08K |
$11.58 | $10.47 | 102.98K |
Nov 14 - Nov 15
| |||
Form 4
| +146.69% | 60K |
—
|
—
| 100.9K |
Jul 6
| |||
Form 4
| +5.01% | 1.95K |
$8.58 | $12.86 | 40.9K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +15.42% | 5.2K |
$5.04 | $3.82 | 38.95K |
Nov 29 - Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +34.97% | 8.74K |
$11.96 | $8.32 | 33.75K |
Nov 11
| |||
Form 4
|
—
|
0
|
$12.43 | -$550,785.67 | 25K |
Scheduled
|
Nov 2
| ||
Form 4
| +177.82% | 16K |
$10.20 | $17.08 | 25K |
Sep 14
| |||
Form 4
|
—
|
0
|
$7.79 | -$669,984.90 | 10K |
Scheduled
|
Mar 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 10K |
$0.57 | $5,700.00 | 10K |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |